Kymera Therapeutics (NASDAQ:KYMR) Director Sells 134,720 Shares
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Bruce Booth sold 134,720 shares of the stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $100.51, for a total transaction of $13,540,707.20. Following the transaction, the director directly owned 597,047 shares in the company, valued at $60,009,193.97. […]
26 Jun 03:08 · The Markets Daily